Liver Cancer Trial, Recruiting NCT06475118 Sponsor: CHU de Reims Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT06475118
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have recently been diagnosed with a type of liver cancer called hepatocellular carcinoma (HCC), confirmed by imaging scans and/or a tissue sample, following standard diagnostic guidelines
  • You have had a specific type of abdominal scan (a three-phase contrast-enhanced CT scan of the abdomen and pelvis) done before starting any treatment

Who may not be able to join:

  • You currently have another active cancer in addition to the liver cancer (HCC)
  • You have an HIV infection that is not currently being controlled with treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 03 26 78 33 43

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
CHU de Reims
Registry
ClinicalTrials.gov
Start date
22 November 2024
Est. completion
22 November 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Determine if serum myokines measured in patients with HCC are correlated with muscle mass index assessed by standard scanographic technique.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov